Skip to main
DOCS

Doximity (DOCS) Stock Forecast & Price Target

Doximity (DOCS) Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 32%
Buy 37%
Hold 32%
Sell 0%
Strong Sell 0%

Bulls say

Doximity is poised for long-term growth due to its strong network and innovative solutions for medical professionals, despite challenges such as market competition and budget constraints. Its impressive financials, including a 58% increase in revenue in 2020 and a strong balance sheet with $1.2 billion in cash, further support this positive outlook. Additionally, with hospitals increasingly utilizing digital solutions, Doximity stands to benefit from the growing adoption of telemedicine and virtual patient visits.

Bears say

Doximity is experiencing slower growth and GM compression due to increased investments in AI, while regulatory uncertainty has resulted in delayed deal signings and a lowered revenue guidance for FY26. Despite a high adoption rate for AI tools, it remains unclear how it will impact financials, and competitor OpenEvidence's entry into the market may pose a threat. With fluctuating growth and uncertainties in the regulatory landscape, the financial outlook for Doximity is unfavorable.

Doximity (DOCS) has been analyzed by 19 analysts, with a consensus rating of Buy. 32% of analysts recommend a Strong Buy, 37% recommend Buy, 32% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Doximity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Doximity (DOCS) Forecast

Analysts have given Doximity (DOCS) a Buy based on their latest research and market trends.

According to 19 analysts, Doximity (DOCS) has a Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $42.84, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $42.84, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Doximity (DOCS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.